Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021616 · ClinicalTrials.gov registry record · NA
Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers
A NA study, sponsored by David Grant U.S. Air Force Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03021616 is a NA study that was terminated before completion, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT03021616, a NA study, was terminated before completion, sponsored by David Grant U.S. Air Force Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study will determine the cardiovascular effects of energy drink consumption in healthy individuals through electrocardiogram (ECG), central blood pressure assessment, and ROTEM® analysis.
Interventions
- OTHER Placebo
- OTHER energy drink
- OTHER Moxifloxacin 400mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2018-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03021616
The ClinicalTrials.gov registry entry for NCT03021616 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Grant U.S. Air Force Medical Center, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03021616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03021616 about?
NCT03021616 is a clinical study titled "Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers". This study will determine the cardiovascular effects of energy drink consumption in healthy individuals through electrocardiogram (ECG), central blood pressure assessment, and ROTEM® analysis.
What is the current status of trial NCT03021616?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-06-26. Estimated completion is 2018-03-13.
What interventions are being tested in trial NCT03021616?
The interventions under investigation include: Placebo (OTHER), energy drink (OTHER), Moxifloxacin 400mg (OTHER).
Who is sponsoring clinical trial NCT03021616?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.